Health-related Quality of Life (hrqol), Functioning, and Symptoms with Odronextamab Monotherapy in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (R/R FL) by POD24 Status in the ELM-2 Study.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要